Jump to content

Recommended Posts


The European Society for Medical Oncology (ESMO) has just had its Annual Conference in Copenhagen.


Click here and here for 2 reports from Practice Update about some of the things discussed at ESMO 2016 and the implications for patients.



Share this post

Link to post
Share on other sites

My doctors have differing views about the Chaarted Trial.


One of my docs advised foregoing chemo for my one bone met and just doing Zytiga/Lupron plus spot radiation. However, two other two docs said to add the chemo -- so now I get to choose!
As reported in biosciencetechnology, a Harvard University and Waterloo University team has found that a common breast cancer chemotherapy can create stem-like cancer cells out of more differentiated tumor cells.   This change in the nature of the tumour cells might be another downside to early chemo with ADT.


Share this post

Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...